Company intelligence / Profile preview

Parrots

Spokane, Washington, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Parrots has developed an AI-powered assistive platform mounted on wheelchairs to facilitate communication and navigation for users with significant motor or speech impairments, such as those with multiple sclerosis or ALS; the product has over 200 early adopters and is deployed commercially, with demonstrated impact on user independence and quality of life[1][3].

Therapeutic areas: Neurology
Modalities: DeviceArtificial intelligence software
Industry: Assistive Medical Devices

Partnerships

NovartisVerizonNational Science FoundationWashington State University (sp3nw incubator, Steve Gleason Institute for Neuroscience)[1]

Beyond the preview

Go deeper on Parrots.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parrots.

Explore the full profile